Active Ingredient: TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)
Proprietary Name: TRIPLE SULFAS
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 167MG/5ML;167MG/5ML;167MG/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N006920
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
Marketing Status:
Discontinued
Patent and Exclusivity Information
Active Ingredient: TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)
Proprietary Name: TRIPLE SULFAS
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 167MG;167MG;167MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N006920
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
Marketing Status:
Discontinued
Patent and Exclusivity Information